Guohui Wan

ResearcherID Scopus Author ID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 19

Top Venues

Nature communications

Molecules (Basel, Switzerland)

Journal of medicinal chemistry

Nature protocols

Sun Yat-Sen University

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Sun Yat-Sen University

China

Professor :: School of Pharmaceutical Sciences

Publications

Bei Wang, Yu Xu, Arabella H Wan, Guohui Wan, G Gregory Neely
Integrating genome-wide CRISPR screens and in silico drug profiling for targeted antidote development. Nature protocols (2024)
Mengxin Yao, Yuan Deng, Zhi-Min Zhao, Depo Yang, Guohui Wan, Xinjun Xu
Selenium Nanoparticles Based on Morinda officinalis Polysaccharides: Characterization, Anti-Cancer Activities, and Immune-Enhancing Activities Evaluation In Vitro. Molecules (Basel, Switzerland) 28 (6) (2023)
Bei Wang, Arabella H Wan, Yu Xu, Ruo-Xin Zhang, Ben-Chi Zhao, Xin-Yuan Zhao, Yan-Chuan Shi, Xiaolei Zhang, Yongbo Xue, Yong Luo, Yinyue Deng, G Gregory Neely, Guohui Wan, G Gregory Neely
Identification of indocyanine green as a STT3B inhibitor against mushroom α-amanitin cytotoxicity. Nature communications 14 (1) (2023)
Zhuolong Zhou, Kevin Van der Jeught, Yujing Li, Samantha Sharma, Tao Yu, Ishara Moulana, Sheng Liu, Jun Wan, Paul R Territo, Mateusz Opyrchal, Xinna Zhang, Guohui Wan, Xiongbin Lu
A T Cell-Engaging Tumor Organoid Platform for Pancreatic Cancer Immunotherapy. Advanced science (Weinheim, Baden-Wurttemberg, Germany) (2023)
Mengxin Yao, Yuan Deng, Zhi-Min Zhao, Depo Yang, Guohui Wan, Xinjun Xu
Selenium Nanoparticles Based on Morinda officinalis Polysaccharides: Characterization, Anti-Cancer Activities, and Immune-Enhancing Activities Evaluation In Vitro. Molecules (Basel, Switzerland) 28 (6) (2023)
Mengxin Yao, Yuan Deng, Zhi-Min Zhao, Depo Yang, Guohui Wan, Xinjun Xu
Selenium Nanoparticles Based on Morinda officinalis Polysaccharides: Characterization, Anti-Cancer Activities, and Immune-Enhancing Activities Evaluation In Vitro. Molecules (Basel, Switzerland) 28 (6) (2023)
Bei Wang, Arabella H Wan, Yu Xu, Ruo-Xin Zhang, Ben-Chi Zhao, Xin-Yuan Zhao, Yan-Chuan Shi, Xiaolei Zhang, Yongbo Xue, Yong Luo, Yinyue Deng, G Gregory Neely, Guohui Wan, G Gregory Neely
Identification of indocyanine green as a STT3B inhibitor against mushroom α-amanitin cytotoxicity. Nature communications 14 (1) (2023)
Bei Wang, Arabella H Wan, Yu Xu, Ruo-Xin Zhang, Ben-Chi Zhao, Xin-Yuan Zhao, Yan-Chuan Shi, Xiaolei Zhang, Yongbo Xue, Yong Luo, Yinyue Deng, G Gregory Neely, Guohui Wan, G Gregory Neely
Identification of indocyanine green as a STT3B inhibitor against mushroom α-amanitin cytotoxicity. Nature communications 14 (1) (2023)
Ziyou Lin, Jingwei Li, Jian Zhang, Weineng Feng, Jiaye Lu, Xiaofan Ma, Wen Ding, Shumin Ouyang, Jin-Jian Lu, Peibin Yue, Guohui Wan, Peiqing Liu, Xiaolei Zhang
Metabolic reprogramming driven by IGF2BP3 promotes acquired resistance to EGFR inhibitors in non-small cell lung cancer. Cancer research (2023)
Zhendong Song, Yi-You Huang, Ke-Qiang Hou, Lu Liu, Feng Zhou, Yue Huang, Guohui Wan, Hai-Bin Luo, Xiao-Feng Xiong
Discovery and Structural Optimization of Toddacoumalone Derivatives as Novel PDE4 Inhibitors for the Topical Treatment of Psoriasis. Journal of medicinal chemistry 65 (5) (2022)
Yunzhi Li, Chaoying Jin, Huiying Xu, Weijian Wu, Youqiao Wang, Jiaxin Wu, Tingyu Liu, Guohui Wan, Xin Yue, Xianzhang Bu
Identification of 2-Benzylidene-tetralone Derivatives as Highly Potent and Reversible Firefly Luciferase Inhibitors. ACS medicinal chemistry letters 13 (2) (2022)
Yuan Deng, Min Xiao, Arabella H Wan, Jiarui Li, Lei Sun, Heng Liang, Qiao-Ping Wang, Sheng Yin, Xianzhang Bu, Guohui Wan
RNA and RNA Derivatives: Light and Dark Sides in Cancer Immunotherapy. Antioxidants & redox signaling (2022)
Yi Niu, Ziyou Lin, Arabella Wan, Lei Sun, Shijia Yan, Heng Liang, Siyue Zhan, Dongshi Chen, Xianzhang Bu, Peiqing Liu, Ceshi Chen, Weiling He, Xiongbin Lu, Guohui Wan
Loss-of-Function Genetic Screening Identifies Aldolase A as an Essential Driver for Liver Cancer Cell Growth Under Hypoxia. Hepatology (Baltimore, Md.) 74 (3) (2022)
Shijia Yan, Guohui Wan
Tumor-associated macrophages in immunotherapy. The FEBS journal 288 (21) (2021)
Lei Sun, Arabella Wan, Zhuolong Zhou, Dongshi Chen, Heng Liang, Chuwei Liu, Shijia Yan, Yi Niu, Ziyou Lin, Siyue Zhan, Shanfeng Wang, Xianzhang Bu, Weiling He, Xiongbin Lu, Anlong Xu, Guohui Wan
RNA-binding protein RALY reprogrammes mitochondrial metabolism via mediating miRNA processing in colorectal cancer. Gut 70 (9) (2020)
Ziyou Lin, Yi Niu, Arabella Wan, Dongshi Chen, Heng Liang, Xijun Chen, Lei Sun, Siyue Zhan, Liutao Chen, Chao Cheng, Xiaolei Zhang, Xianzhang Bu, Weiling He, Guohui Wan
RNA m6 A methylation regulates sorafenib resistance in liver cancer through FOXO3-mediated autophagy. The EMBO journal 39 (12) (2020)
Yanqiao Feng, Hui Su, Yunzhi Li, Chunxiang Luo, Huiying Xu, Youqiao Wang, Haixia Sun, Guohui Wan, Binhua Zhou, Xianzhang Bu
Degradation of intracellular TGF-β1 by PROTACs efficiently reverses M2 macrophage induced malignant pathological events. Chemical communications (Cambridge, England) 56 (19) (2020)
Haixia Sun, Daoyuan Chen, Siyue Zhan, Weijian Wu, Huiying Xu, Chunxiang Luo, Hui Su, Yanqiao Feng, Weiyan Shao, Arabella Wan, Binhua Zhou, Guohui Wan, Xianzhang Bu
Design and Discovery of Natural Cyclopeptide Skeleton Based Programmed Death Ligand 1 Inhibitor as Immune Modulator for Cancer Therapy. Journal of medicinal chemistry 63 (19) (2020)
Yi Niu, Ziyou Lin, Arabella Wan, Honglei Chen, Heng Liang, Lei Sun, Yuan Wang, Xi Li, Xiao-Feng Xiong, Bo Wei, Xiaobin Wu, Guohui Wan
RNA N6-methyladenosine demethylase FTO promotes breast tumor progression through inhibiting BNIP3. Molecular cancer 18 (1) (2019)

Guohui Wan

Publication Activity (10 Years)

Top Topics

Top Venues